TNFα sensitizes neuroblastoma cells to FasL-, cisplatin- and etoposide-induced cell death by NF-κB-mediated expression of Fas

Abstract

BackgroundPatients with high-risk neuroblastoma (NBL) tumors have a high mortality rate. Consequently, there is an urgent need for the development of new treatments for this condition. Targeting death receptor signaling has been proposed as an alternative to standard chemo- and radio-therapies in various tumors. In NBL, this therapeutic strategy has been largely disregarded, possibly because ~50-70% of all human NBLs are characterized by caspase-8 silencing. However, the expression of caspase-8 is detected in a significant group of NBL patients, and they could therefore benefit from treatments that induce cell death through death receptor activation. Given that cytokines, such as TNFα, are able to upregulate Fas expression, we sought to address the therapeutic relevance of co-treatment with TNFα and FasL in NBL.MethodsFor the purpose of the study we used a set of eight NBL cell lines. Here we explore the cell death induced by TNFα, FasL, cisplatin, and etoposide, or a combination thereof by Hoechst staining and calcein viability assay. Further assessment of the signaling pathways involved was performed by caspase activity assays and Western blot experiments. Characterization of Fas expression levels was achieved by qRT-PCR, cell surface biotinylation assays, and cytometry.ResultsWe have found that TNFα is able to increase FasL-induced cell death by a mechanism that involves the NF-κB-mediated induction of the Fas receptor. Moreover, TNFα sensitized NBL cells to DNA-damaging agents (i.e. cisplatin and etoposide) that induce the expression of FasL. Priming to FasL-, cisplatin-, and etoposide-induced cell death could only be achieved in NBLs that display TNFα-induced upregulation of Fas. Further analysis denotes that the high degree of heterogeneity between NBLs is also manifested in Fas expression and modulation thereof by TNFα.ConclusionsIn summary, our findings reveal that TNFα sensitizes NBL cells to FasL-induced cell death by NF-κB-mediated upregulation of Fas and unveil a new mechanism through which TNFα enhances the efficacy of currently used NBL treatments, cisplatin and etoposide.Electronic supplementary materialThe online version of this article (doi:10.1186/s12943-015-0329-x) contains supplementary material, which is available to authorized users.

Gastrodin Protects against Ethanol-Induced Liver Injury and Apoptosis in HepG2 Cells and Animal Models of Alcoholic Liver Disease

“…In addition to the mitochondrial apoptotic pathway, ethanol also stimulates the extrinsic apoptotic pathway, which is mediated by death receptors like Fas and the Fas ligand (FasL). 31) Fas and FasL are target genes of nuclear factor-B (NF-κB), 32) and GSTD has been shown to suppress proinflammatory response through blocking the NF-κB pathway. 33) It is possible that GSTD may also inhibit the extrinsic apoptotic pathway in preventing ethanol-induced hepatocellular apoptosis, which merits further investigation.…”

Second-generation proteasome inhibitor carfilzomib sensitizes neuroblastoma cells to doxorubicin-induced apoptosis

“…Elevated NF-κB activation in cancer cells promotes tumor survival and progression [19–21]. In NB, the up-regulation of NF-κB has been shown to accelerate tumor growth and promote cancer cell survival [1, 19, 22, 23].…”

Fas-FasL expression and myocardial cell apoptosis in patients with viral myocarditis

“…Viral myocarditis is a common infectious form of acute or chronic heart muscle inflammation, which can be characterized as either localized or diffuse inflammatory lesions, and is highly related to viral infection (Galenkamp et al, 2015). Generally, more than 5% of individuals with a viral infection will experience some form of myocarditis during the infection period with different clinical manifestations.…”